top of page
Our team brought Okapi Sciences from a series A in 2008 to a healthy acquisition in 2014. The same team has merged Okapi Sciences’ livestock assets with innovations at Academia to form ViroVet. Currently we are approaching 20 FTE. Our company was elected as 2015 and 2017 startup of the year by Animal Pharm News. You can meet and connect with our board members, the management, our advisors and our investors by clicking below.
Board of Directors
Management & Advisors
Investors
Erwin Blomsma
CEO ViroVet
Ludwig Goris
for CSCF
Thomas Beke
for PMV
Patrik Haesen
for AIF
Laetitia Gerbe
for Seventure Partners
Yannick Vancoppenolle
for VIVES
Ilse Sienaert
for GFF / KU Leuven
Erwin Blomsma
CEO & Co-Founder
Nesya Goris
CDO & Co-Founder
Stefaan Wera
COO & Co-Founder
Bart Crijns
Finance Director
George Gunn
Strategic Advisor
AIF
Agri Investment Fund
PMV
Biotech Fonds Vlaanderen
CSCF
Capricorn Sustainable Chemistry Fund
GFF
Gemma Frisius Fund
VIVES
Louvain Technology Fund
Seventure Partners
AVF Fund
bottom of page